The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...
Zacks Investment Research on MSN
Why DexCom (DXCM) is a top growth stock for the long term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Young and the Invested on MSN
Growth stocks are hurting, but Wall Street still loves these 7 picks
This article discusses the best growth stocks to buy right now.
As much as I try to advocate for being childfree in every conversation I can, it’s still harrowing and disturbing to see a ...
Experience From Brazilian and Australian Clinical Trials Positions the Company to Submit Investigational Device Exemption (IDE) to FDA for Novel CBGM Technology in Q2 2026RUTHERFORD, N.J., March 27, ...
MiraLAX is an over-the-counter (OTC) laxative powder containing polyethylene glycol 3350 for use to relieve constipation. It is intended for adults and children ages 17 years and older. The ...
Background: Although brain and heart conditions share overlapping risk factors and commonly co-occur, current cardiac and neurologic clinical guidelines are typically produced within specialty silos.
Glucotrack (Nasdaq:GCTK) today provided an update on the planned regulatory timeline for its continuous blood glucose monitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results